Altius Strategy

Altius Strategy Consulting helps companies plan for the commercial success of medical products and services through the creation and demonstration of value.

[Luke Timmerman @ldtimmerman]

Leora Schiff @LeoraSchiff @AltiusStrategy and Jeff Berkowitz of Real Endpoints on finding a fair way to pay for the new cancer meds. Berkowitz: 'In US, value is in the eye of the beholder. And the beholder is the payor.' #BOScancersummit

[Timmerman Report @timmermanreport]

Has the Time Come for a US NICE? In-depth piece on how to think about cost-effectiveness by TR contributor @LeoraSchiff @AltiusStrategy (Sub Req.) https://t.co/5Pz1L4sXKc

[Altius Strategy @AltiusStrategy]

See the latest article by @AltiusStrategy Principal @LeoraSchiff on proposed policy changes for Medicare Part B and Part D drugs.

[Timmerman Report @timmermanreport]

The ABC's (and D's) of Changing Medicare Drug Policy. TR contributor @LeoraSchiff goes under the hood with Medicare Part B and D proposed changes that could have big impact on biopharma. https://t.co/8fnf1uEQCX

[Altius Strategy @AltiusStrategy]

@AltiusStrategy Principal, @LeoraSchiff, writes about the confusion and misalignment in current Medicare reimbursement for CAR-T therapies Kymriah and Yescarta. Check out her insights in"Medicare's CAR (-T) Wreck" @timmmermanreport.

[Timmerman Report @timmermanreport]

Medicare's CAR (-T) Wreck. Terrific context from TR contributing writer @LeoraSchiff @AltiusStrategy https://t.co/NtCKcUDcen

[Altius Strategy @AltiusStrategy]

Altius Principal, @LeoraSchiff spoke about the progress of immunotherapies to date and the challenges ahead at an educational forum for Asia-Pacific payers at the ISPOR conference in Tokyo.

[Altius Strategy @AltiusStrategy]

Altius Principal, Leora Schiff looks at the complexities of why some patients may not benefit from immunotherapy, and what this means for future IO biomarkers and precision medicine to select the right combination immunotherapy for the right patient. https://t.co/lYJDRzGB0p

[Timmerman Report @timmermanreport]

Getting to Precision Medicine for I-O Combos -- it's Even More Complicated. By @LeoraSchiff https://t.co/d3Ni6RvWvh

[Altius Strategy @AltiusStrategy]

Altius Principal @LeoraSchiff published an overview of recent state legislation on drug price transparency and controls in @TimmermanReport . https://t.co/5aQSlDVOJg

[Timmerman Report @timmermanreport]

State Laws Zero in on Drug Prices. By @LeoraSchiff https://t.co/lqHkfFLnES

[Altius Strategy @AltiusStrategy]

@AltiusStrategy Principal, @LeoraSchiff explains why developing companion diagnostic tests for immunotherapies has been a challenge. https://t.co/A3b0Jo2Hit

[Timmerman Report @timmermanreport]

Getting to Precision Oncology -- It's Complicated. By @LeoraSchiff https://t.co/grE46bc6Oo

[Altius Strategy @AltiusStrategy]

@AltiusStrategy Principal Leora Schiff discussed healthcare system with outgoing Genzyme Sanofi CEO David Meeker: https://t.co/t0cmT3xRht

[Altius Strategy @AltiusStrategy]

Altius' Leora Schiff discussed drug value with Sanofi's Bill Sibold, Allergan's David Nicholson, MIT's Gigi Hirsh and Tuft's Joshua Cohen. https://t.co/EBNcsVfya3

[Laura Hamilton @LHamilton822]

ValuePanel-HealthEconomics requisite for new drugs @AltiusStrategy @TuftsMedicalCtr NewDigs @Allergan @SanofiGenzyme @massbio #MassBioAM17

[Altius Strategy @AltiusStrategy]

Altius Principal, Leora Schiff publishes Trump Policy Checklist: Where Things Stand on 7 Big Biopharma Issues on @TimmermanReport https://t.co/IWU0Mwdiry

[Leora Schiff @LeoraSchiff]

Just published an article on potential impact of Trump healthcare policies on biopharma. Could all change tomorrow! https://t.co/ZdT8SLMziX

[Altius Strategy @AltiusStrategy]

Altius Principal Leora Schiff moderates plenary on Biotech in the Era of Real World Evidence @MassBio Annual Meeting https://t.co/nNIht6l0fS

[Altius Strategy @AltiusStrategy]

Altius principal Leora Schiff to moderate Changing Administration, Changing Policy at BioEurope Spring - discussion of Trump Admin policies.

[Altius Strategy @AltiusStrategy]

Meet with Altius Principal, Leora Schiff at BioEurope Spring in Barcelona, 3/20 - 3/22/17. https://t.co/iPG2AFKc9Q

[Altius Strategy @AltiusStrategy]

Join Altius Principal Leora Schiff discussion of US reimbursement at CBI Oncology Commercialization & MA, 2/28 - 3/1 https://t.co/CtoM8XFLlK

[Altius Strategy @AltiusStrategy]

Altius Principal, Leora Schiff moderates panels on Value Frameworks and US Reimbursement @CBI_conferences Oncology Commercialization & MA.

[Altius Strategy @AltiusStrategy]

Part 2 Hiring Women Execs in Biotech and VC Firms is a Moneyball Play by Leora Schiff and Kyle Serikawa now in TR. https://t.co/o1uXH38QAI

[Altius Strategy @AltiusStrategy]

Altius Principal,@LeoraSchiff and @kyleserikawa discuss business advantages of hiring women execs and VC partners. https://t.co/84OFCG8rr5

[Altius Strategy @AltiusStrategy]

Read Part 2 of Altius Principal, Leora Schiff's interview with Steve Miller of Express Scripts: https://t.co/FEE3Yri80f

[Altius Strategy @AltiusStrategy]

@AltiusStrategy Principal @LeoraSchiff joins an expert panel to discuss oncology value-based contracting. Webinar is on Feb 3 at 2pm EST. https://t.co/GHDbHEgBNU

[Reuters Events Pharma @RE_Pharma]

Value-based contracting in Oncology - Pharma are you ready? Join this free webinar here https://t.co/3VggNBoCmo @LillyPad